Beijing Chunlizhengda Medical Instruments Co., Ltd.

SEHK:1858 Stock Report

Market Cap: HK$4.6b

Beijing Chunlizhengda Medical Instruments Future Growth

Future criteria checks 5/6

Beijing Chunlizhengda Medical Instruments is forecast to grow earnings and revenue by 29.6% and 22% per annum respectively. EPS is expected to grow by 30.2% per annum. Return on equity is forecast to be 10.4% in 3 years.

Key information

29.6%

Earnings growth rate

30.2%

EPS growth rate

Medical Equipment earnings growth42.9%
Revenue growth rate22.0%
Future return on equity10.4%
Analyst coverage

Low

Last updated19 Oct 2024

Recent future growth updates

Recent updates

Investors Still Waiting For A Pull Back In Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

Sep 30
Investors Still Waiting For A Pull Back In Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858) Analysts Just Slashed This Year's Revenue Estimates By 13%

Sep 11
Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858) Analysts Just Slashed This Year's Revenue Estimates By 13%

Beijing Chunlizhengda Medical Instruments' (HKG:1858) Upcoming Dividend Will Be Larger Than Last Year's

Jul 01
Beijing Chunlizhengda Medical Instruments' (HKG:1858) Upcoming Dividend Will Be Larger Than Last Year's

The Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Don't Inspire Confidence

May 25
The Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Don't Inspire Confidence

We Think You Can Look Beyond Beijing Chunlizhengda Medical Instruments' (HKG:1858) Lackluster Earnings

Apr 04
We Think You Can Look Beyond Beijing Chunlizhengda Medical Instruments' (HKG:1858) Lackluster Earnings

Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) Shareholders Might Be Looking For Exit

Jan 06
Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) Shareholders Might Be Looking For Exit

Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Paint A Concerning Picture

Dec 06
Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Paint A Concerning Picture

Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Paint A Concerning Picture

Aug 31
Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Paint A Concerning Picture

Here's What's Concerning About Beijing Chunlizhengda Medical Instruments' (HKG:1858) Returns On Capital

Apr 11
Here's What's Concerning About Beijing Chunlizhengda Medical Instruments' (HKG:1858) Returns On Capital

Here's What To Make Of Beijing Chunlizhengda Medical Instruments' (HKG:1858) Decelerating Rates Of Return

Dec 05
Here's What To Make Of Beijing Chunlizhengda Medical Instruments' (HKG:1858) Decelerating Rates Of Return

Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Have Hit The Brakes

Apr 28
Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Have Hit The Brakes

I Built A List Of Growing Companies And Beijing Chunlizhengda Medical Instruments (HKG:1858) Made The Cut

Dec 30
I Built A List Of Growing Companies And Beijing Chunlizhengda Medical Instruments (HKG:1858) Made The Cut

Beijing Chunlizhengda Medical Instruments (HKG:1858) Could Become A Multi-Bagger

Dec 06
Beijing Chunlizhengda Medical Instruments (HKG:1858) Could Become A Multi-Bagger

Is Now The Time To Put Beijing Chunlizhengda Medical Instruments (HKG:1858) On Your Watchlist?

Sep 24
Is Now The Time To Put Beijing Chunlizhengda Medical Instruments (HKG:1858) On Your Watchlist?

We Like Beijing Chunlizhengda Medical Instruments' (HKG:1858) Returns And Here's How They're Trending

Sep 06
We Like Beijing Chunlizhengda Medical Instruments' (HKG:1858) Returns And Here's How They're Trending

We Take A Look At Whether Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) CEO May Be Underpaid

Jun 15
We Take A Look At Whether Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) CEO May Be Underpaid

Here's Why We Think Beijing Chunlizhengda Medical Instruments (HKG:1858) Is Well Worth Watching

Jun 05
Here's Why We Think Beijing Chunlizhengda Medical Instruments (HKG:1858) Is Well Worth Watching

Beijing Chunlizhengda Medical Instruments (HKG:1858) Could Become A Multi-Bagger

May 09
Beijing Chunlizhengda Medical Instruments (HKG:1858) Could Become A Multi-Bagger

Beijing Chunlizhengda Medical Instruments Co., Ltd. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Apr 01
Beijing Chunlizhengda Medical Instruments Co., Ltd. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Earnings and Revenue Growth Forecasts

SEHK:1858 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,5923743333623
12/31/20251,3443142422593
12/31/20241,1272631473233
9/30/2024925158450481N/A
6/30/20241,048231446482N/A
3/31/20241,184277457502N/A
12/31/20231,209278478512N/A
9/30/20231,234279129131N/A
6/30/20231,1712776784N/A
3/31/20231,191290-64-59N/A
12/31/20221,2023081641N/A
9/30/20221,150328-4330N/A
6/30/20221,197324-4964N/A
3/31/20221,139328-34134N/A
12/31/20211,108322-35165N/A
9/30/2021984287-10177N/A
6/30/20211,013322137256N/A
3/31/20211,007318227303N/A
12/31/2020938283237261N/A
9/30/2020913264173249N/A
6/30/2020887244109238N/A
3/31/202082621669191N/A
12/31/201985523799232N/A
9/30/201975820168161N/A
6/30/20196601643791N/A
3/31/201957913547100N/A
12/31/201849810656109N/A
9/30/20184449472111N/A
6/30/201838983N/A113N/A
3/31/201834576N/A102N/A
12/31/201730068N/A90N/A
9/30/201726165N/A86N/A
6/30/201722163N/A82N/A
3/31/201721563N/A73N/A
12/31/201620863N/A65N/A
9/30/201620155N/A46N/A
6/30/201619547N/A27N/A
3/31/201618643N/A13N/A
12/31/201517738N/A-1N/A
9/30/201517947N/A7N/A
6/30/201516344N/A-16N/A
3/31/201514941N/A4N/A
12/31/201413537N/A24N/A
9/30/201412937N/A40N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1858's forecast earnings growth (29.6% per year) is above the savings rate (2.3%).

Earnings vs Market: 1858's earnings (29.6% per year) are forecast to grow faster than the Hong Kong market (11.3% per year).

High Growth Earnings: 1858's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 1858's revenue (22% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).

High Growth Revenue: 1858's revenue (22% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 1858's Return on Equity is forecast to be low in 3 years time (10.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 22:10
End of Day Share Price 2025/01/28 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Chunlizhengda Medical Instruments Co., Ltd. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wai Ming KongDBS Bank Ltd
Wai Ming KongDBS Vickers Research
Chao ZhangGuosen Securities Co., Ltd.